These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36900957)

  • 1. Epidemiological Characteristics of Notifiable Respiratory Infectious Diseases in Mainland China from 2010 to 2018.
    Deng L; Han Y; Wang J; Liu H; Li G; Wang D; He G
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological characteristics of seven notifiable respiratory infectious diseases in the mainland of China: an analysis of national surveillance data from 2017 to 2021.
    Deng LL; Han YJ; Li ZW; Wang DY; Chen T; Ren X; He GX
    Infect Dis Poverty; 2023 Nov; 12(1):99. PubMed ID: 37953290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological characteristics of imported respiratory infectious diseases in China, 2014‒2018.
    Wang JL; Chen T; Deng LL; Han YJ; Wang DY; Wang LP; He GX
    Infect Dis Poverty; 2022 Mar; 11(1):22. PubMed ID: 35246236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notifiable Respiratory Infectious Diseases in China: A Spatial-Temporal Epidemiology Analysis.
    Mao Y; He R; Zhu B; Liu J; Zhang N
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32235375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of spatial-temporal distribution of notifiable respiratory infectious diseases in Shandong Province, China during 2005-2014.
    Li X; Chen D; Zhang Y; Xue X; Zhang S; Chen M; Liu X; Ding G
    BMC Public Health; 2021 Aug; 21(1):1597. PubMed ID: 34461855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological features and trends in the mortality rates of 10 notifiable respiratory infectious diseases in China from 2004 to 2020: Based on national surveillance.
    Zhao N; Wang S; Wang L; Shi Y; Jiang Y; Tseng TJ; Liu S; Chan TC; Zhang Z
    Front Public Health; 2023; 11():1102747. PubMed ID: 36875408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019.
    Du M; Wang R; Yuan J; Lv X; Yan W; Liu Q; Qin C; Xiang N; Zhu L; Liang W; Liu M; Liu J
    J Med Virol; 2023 Jan; 95(1):e28353. PubMed ID: 36443103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of morbidity and mortality characteristics of the notifiable diseases reported in 2013 in China].
    Wang L; Zeng L; Ren X; Geng M; Li Z; Yu H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Mar; 36(3):194-8. PubMed ID: 25975392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.
    Ciofi Degli Atti ML; Salmaso S; Bella A; Arigliani R; Gangemi M; Chiamenti G; Brusoni G; Tozzi AE;
    Pediatr Infect Dis J; 2002 Aug; 21(8):763-8. PubMed ID: 12192166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological characteristics of mumps in mainland China from 2004 to 2018 and key population for prevention and control].
    Jiang RJ; Yin QZ; Xu MJ; Zhao ZM; Deng Y; Che YC
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 May; 21(5):441-444. PubMed ID: 31104659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal and Seasonal Trends of Class A and B Notifiable Infectious Diseases in China: Retrospective Analysis.
    Zheng J; Zhang N; Shen G; Liang F; Zhao Y; He X; Wang Y; He R; Chen W; Xue H; Shen Y; Fu Y; Zhang WH; Zhang L; Bhatt S; Mao Y; Zhu B
    JMIR Public Health Surveill; 2023 Apr; 9():e42820. PubMed ID: 37103994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impact of COVID-19 non-pharmaceutical interventions and relaxation policies on Class B respiratory infectious diseases transmission in China.
    Wu N; Guan P; An S; Wang Z; Huang D; Ren Y; Wu W
    Sci Rep; 2024 Sep; 14(1):21197. PubMed ID: 39261569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to select a proper early warning threshold to detect infectious disease outbreaks based on the China infectious disease automated alert and response system (CIDARS).
    Wang R; Jiang Y; Michael E; Zhao G
    BMC Public Health; 2017 Jun; 17(1):570. PubMed ID: 28606078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measles, pertussis, rubella and mumps completeness of reporting. Literature review of estimates for industrialized countries].
    Trottier H; Carabin H; Philippe P
    Rev Epidemiol Sante Publique; 2006 Feb; 54(1):27-39. PubMed ID: 16609635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017.
    Dong Y; Wang L; Burgner DP; Miller JE; Song Y; Ren X; Li Z; Xing Y; Ma J; Sawyer SM; Patton GC
    BMJ; 2020 Apr; 369():m1043. PubMed ID: 32241761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infectious diseases in Poland in 2000].
    Mazurek J; Czarkowski MP
    Przegl Epidemiol; 2002; 56(2):217-25. PubMed ID: 12371353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surveillance data on notifiable infectious diseases among students aged 6-22 years in China, 2011-2016].
    Sun J; Yang WW; Zeng LJ; Geng MJ; Dong YH; Xing Y; Ma J; Li ZJ; Wang LP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1589-1595. PubMed ID: 30572383
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dramatic achievements in infectious disease prevention and treatment in China during the past 70 years].
    Yang WZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Dec; 40(12):1493-1498. PubMed ID: 32062906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.
    Chen B; Wang M; Huang X; Xie M; Pan L; Liu H; Liu Z; Zhou P
    Front Public Health; 2021; 9():728768. PubMed ID: 34722440
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of national COVID-19 restrictions on incidence of notifiable communicable diseases in England: an interrupted time series analysis.
    Nash K; Lai J; Sandhu K; Chandan JS; Shantikumar S; Ogunlayi F; Coleman PC
    BMC Public Health; 2022 Dec; 22(1):2318. PubMed ID: 36510205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.